Dagster (orchestration tool) is complementary to dbt core (open source CLI tool for defining data transformation jobs) but competitive to dbt cloud (SaaS, orchestrates dbt jobs).
On Tuesday, Loyal for Dogs announced that its first-of-its-kind longevity drug received the first of three green lights needed for FDA approval. The decision, made in early November, is essentially a vote of confidence from federal regulators that this drug should actually work to extend dogs' lifespans, based on evidence so far.
Not GP, but https://fourminutebooks.com comes to mind. It's also just incredibly useful to get a "4 minute precis" and decide whether or not it's worth it to you to spend more time on that book.
This is a beautiful app - my problem with tools like this is I don't use a Kindle so ingesting highlights is painful, but I'll plan on giving this a shot nevertheless.
Having the same debate - feels like this supports a better variety of sources, but Matter has a better/simpler UI for web articles & newsletters specifically.
That's a good data point, the market is surprisingly small which could account for lack of competition. But the last annual report has the ticketing org alone at 37% EBITDA margin [1] (they call it AOI). No expert on benchmarking this # but wouldn't say they're not milking it.
37% EBITDA is in line with APPL (31%) and relatively low when you consider that APPL produces a ton of actual physical goods.
It seems that companies that go much above 35% start "investing" in stupid shit (FB hit 50% EBITDA margin in 2018 and then went nuts with Meta, dragging themselves back down to the 30s).
I'd say that these are rookie numbers and they could get that stuff to 50% or more (though some of it they wash into the venue and book on another part of the ledger).
